Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. November 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen to Present at 2015 Credit Suisse Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
06. Oktober 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen Announces Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., Oct. 6, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
15. September 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen to Present Data on Plazomicin at 55th Annual ICAAC Meeting

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
19. August 2015 16:15 ET | Quelle: Achaogen, Inc.

Achaogen Appoints Blake Wise as Chief Operating Officer

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
10. August 2015 09:00 ET | Quelle: Achaogen, Inc.

Achaogen Announces Second Quarter 2015 Results

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
05. August 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen to Present at the 2015 Wedbush PacGrow Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
21. Juli 2015 16:15 ET | Quelle: Achaogen, Inc.

Achaogen Announces Employment Inducement Grants

SOUTH SAN FRANCISCO, Calif., July 21, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
16. Juli 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen Awarded $4.5 Million Contract With NIAID for Development of Novel LpxC Inhibitors for the Treatment of Bacterial Infections

SOUTH SAN FRANCISCO, July 16, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR)...
01. Juli 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

SOUTH SAN FRANCISCO, Calif., July 1, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...
15. Juni 2015 05:30 ET | Quelle: Achaogen, Inc.

Achaogen to Participate in BIO and AIA Events Focused on Incentivizing Antibiotic Development

SOUTH SAN FRANCISCO, Calif., June 15, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant...

Vorherige Seite

Nächste Seite